FR607M - - Google Patents
Info
- Publication number
- FR607M FR607M FR837423A FR837423A FR607M FR 607 M FR607 M FR 607M FR 837423 A FR837423 A FR 837423A FR 837423 A FR837423 A FR 837423A FR 607 M FR607 M FR 607M
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR837423A FR607M (en:Method) | 1958-03-13 | 1961-08-31 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72110458A | 1958-03-13 | 1958-03-13 | |
| FR789324A FR1268445A (fr) | 1958-03-13 | 1958-03-13 | Dérivés de la pyrrolo [2. 3-d] pyrimidine et leur préparation |
| FR837423A FR607M (en:Method) | 1958-03-13 | 1961-08-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FR607M true FR607M (en:Method) | 1961-06-19 |
Family
ID=24896553
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR837423A Active FR607M (en:Method) | 1958-03-13 | 1961-08-31 |
Country Status (3)
| Country | Link |
|---|---|
| ES (1) | ES247857A1 (en:Method) |
| FR (1) | FR607M (en:Method) |
| GB (2) | GB915303A (en:Method) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3311628A (en) * | 1965-03-09 | 1967-03-28 | Bristol Myers Co | Derivatives of pyrrolo [2, 3-d] pyrimidine |
| CH592668A5 (en:Method) * | 1973-10-02 | 1977-10-31 | Delalande Sa | |
| DE59500788D1 (de) * | 1994-05-03 | 1997-11-20 | Ciba Geigy Ag | Pyrrolopyrimidinderivate mit antiproliferativer Wirkung |
| US6686366B1 (en) | 1998-06-02 | 2004-02-03 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A3 receptor and uses thereof |
| US6878716B1 (en) | 1998-06-02 | 2005-04-12 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A1 receptor and uses thereof |
| AU763658B2 (en) | 1998-06-02 | 2003-07-31 | Osi Pharmaceuticals, Inc. | Pyrrolo(2,3d)pyrimidine compositions and their use |
| IL139586A0 (en) * | 1998-06-19 | 2002-02-10 | Pfizer Prod Inc | PYRROLO [2,3-d] PYRIMIDINE COMPOUNDS |
| PA8474101A1 (es) | 1998-06-19 | 2000-09-29 | Pfizer Prod Inc | Compuestos de pirrolo [2,3-d] pirimidina |
| US6664252B2 (en) | 1999-12-02 | 2003-12-16 | Osi Pharmaceuticals, Inc. | 4-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereof |
| US6680322B2 (en) | 1999-12-02 | 2004-01-20 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A1 receptors and uses thereof |
| US7160890B2 (en) | 1999-12-02 | 2007-01-09 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A3 receptor and uses thereof |
| TR200201498T2 (tr) | 1999-12-10 | 2003-01-21 | Pfizer Products Inc. | Pirrolo [2,3-d] pirimidin bileşikleri. |
| US6680324B2 (en) | 2000-12-01 | 2004-01-20 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A1 receptors and uses thereof |
| US6673802B2 (en) | 2000-12-01 | 2004-01-06 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A3 receptor and uses thereof |
| DE10148883A1 (de) * | 2001-10-04 | 2003-04-10 | Merck Patent Gmbh | Pyrimidinderivate |
| DE60234118D1 (de) | 2001-11-30 | 2009-12-03 | Osi Pharm Inc | Verbindungen, die für Adenosin A1 und A3 Rezeptoren spezifisch sind, und deren Anwendungen |
| CN1620294A (zh) | 2001-12-20 | 2005-05-25 | Osi药物公司 | 嘧啶a2b选择性拮抗剂化合物,它们的合成及用途 |
| CN1816551A (zh) | 2001-12-20 | 2006-08-09 | Osi药物公司 | 吡咯并嘧啶A2b选择性拮抗剂化合物,它们的合成及用途 |
| AU2003276591A1 (en) | 2002-11-26 | 2004-06-18 | Pfizer Products Inc. | Method of treatment of transplant rejection |
| TW200738709A (en) * | 2006-01-19 | 2007-10-16 | Osi Pharm Inc | Fused heterobicyclic kinase inhibitors |
| PL2384326T3 (pl) | 2008-08-20 | 2014-09-30 | Zoetis Services Llc | Związki pirolo[2,3-d]pirymidyonowe |
| NL2022471B1 (en) | 2019-01-29 | 2020-08-18 | Vationpharma B V | Solid state forms of oclacitinib |
-
1959
- 1959-03-09 GB GB8013/59A patent/GB915303A/en not_active Expired
- 1959-03-09 GB GB32973/61A patent/GB915304A/en not_active Expired
- 1959-04-12 ES ES0247857A patent/ES247857A1/es not_active Expired
-
1961
- 1961-08-31 FR FR837423A patent/FR607M/fr active Active
Also Published As
| Publication number | Publication date |
|---|---|
| GB915304A (en) | 1963-01-09 |
| GB915303A (en) | 1963-01-09 |
| ES247857A1 (es) | 1959-08-16 |